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Abstract
Background: Aspergillus tubingensis is a black Aspergillus belonging to the Aspergillus section Nigri, which includes
species that morphologically resemble Aspergillus niger. Recent developments in species determination have
resulted in clinical isolates presumed to be Aspergillus niger being reclassified as Aspergillus tubingensis by
sequencing. We present a report of a patient with an osteomyelitis of the maxillary bone with a probable invasive
Aspergillus tubingensis infection.
Case presentation: We describe an immune compromised patient suffering from osteomyelitis of the maxillary
bone after tooth extraction. The osteomyelitis probably resulted in dentogenic pansinusitis presenting as an acute
ethmoiditis. Histologic examination of biopsy samples showed osteomyelitis, and inflammation of the surrounding
connective tissue. Cultures of the alveolar wound grew Aspergillus tubingensis. The patient was treated with
liposomal amphoterocin B, which was changed to oral treatment with voriconazole based on susceptibility testing
(MIC for voriconazole was 1 μg/ml).
Conclusion: This case shows that Aspergillus tubingensis may have the potential to cause severe invasive infections
in immunocompromised hosts. A larger proportion of Aspergillus tubingensis isolates are less susceptible to azoles
compared to Aspergillus niger. Therefore, correct species identification and susceptibility testing is crucial for the
choice of anti-fungal treatment, screening of azole resistance, and characterization of the pathogenic potential of
the various species within Aspergillus section Nigri.
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Background
Aspergillus tubingensis is a black Aspergillus species
described by Raoul Mosseray in 1934 [1]. This species is
found all over the world, grows predominantly on dead
plant material, and is food associated [2]. A. tubingensis
belongs to the Aspergillus section Nigri, which also
includes A. niger, and A. awamori amongst a total of 25
species [2-4]. The species belonging to the Aspergillus
section Nigri are phylogenetically closely related. This
makes the taxonomy and species determination difficult.
In general, species can be distinguished via a polyphasic
approach using morphology, biochemical properties, and
molecular data [3,5]; however, most of the species
belonging to the Aspergillus section Nigri are morpho-
logically indistinguishable. Several species do have some
distinct biochemical properties: nutritional growth con-
ditions and hydrolase differences between the species
have been described [6]. Furthermore, production of sec-
ondary metabolites is often unique for a species within
Aspergillus section Nigri, and could be used for identifi-
cation [2], but it is not yet possible to differentiate the
species solely on metabolic properties.
Due to the above mentioned difficulties in discrimination
of species, the most commonly used method for species
identification of Aspergillus section Nigri is sequencing.
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Using calmodulin or β-tubulin data sequencing data, all
Aspergillus section Nigri species can be clearly distin-
guished [3]. The development of these molecular diagnos-
tic tools has facilitated correct species determination of
black Aspergilli.
In this report, we describe a patient with a probable
invasive infection with A. tubingensis, and discuss the
clinical importance of A. tubingensis and its correct spe-
cies determination.
Case presentation
A 19-year-old male patient born in the Netherlands
(Moroccan parents) presented with fever, rhinitis and
progressive pain behind the left eye. His recent medical
record included a second non-myeloablative stem cell
transplantation for graft failure resulting in relapse of
paroxysmal nocturnal haemoglobinuria 3 weeks prior to
presentation. He had undergone a maxillary tooth ex-
traction 47 days prior to presentation. The alveolar
wound did not heal due to osteomyelitis, for which he
had a biopsy of the maxillary bone 23 days prior to pres-
entation. Histological examination of the biopsy samples
showed necrotic bone tissue. The surrounding connect-
ive tissue was infiltrated by leukocytes. Yeast cells, and
focal bacterial colonies were noted. He was treated em-
pirically with amoxicillin/clavulanic acid orally, which
had been started 3 days prior to presentation, and the
immunosuppressive drugs cyclosporine, mycophenolic
acid, and prednisone. With this treatment, the patient
was clinically deteriorating.
Physical examination revealed a body temperature of
37.9°C and normal vital signs. A purulent wound in the
mouth resulting from the biopsy, left pre-orbital swelling,
and painful cervical lymphadenopathy were observed. La-
boratory tests showed increased C-reactive protein at
346 mg/L, leucopenia (leukocytes < 0.1 × 109/L), thrombo-
penia (thrombocytes 32 × 109/L) and normocytic anaemia
(haemoglobin 5.51 × 109/L). Computed tomography of the
head showed pre-orbital swelling with induration of the
subcutis, swollen mucosa of the sphenoid, and maxillary
sinus, and total opacification of the left ethmoid sinus
(Figure 1). Since a direct surgical approach was impossible
due to extensive bleeding of the swollen mucosa, an
antrostomy was performed and sinus secretions were thor-
oughly aspirated. Cultures of purulent fluid from the
biopsy wound in the mouth on Sabouraud dextrose agar at
37.0°C grew a black Aspergillus, morphologically resem-
bling A. niger. Cultures of the aspirated secretion from
sinus cavities were negative for bacteria and fungi. Results
of the histological examination of mucosal lining samples
of the nasal sinus were consistent with chronic sinusitis.
The result of molecular identification of the black Aspergil-
lus by sequencing of the β-tubilin gene was A. tubingensis
Mosseray (CBS-KNAW, Fungal Biodiversity Centre,
Utrecht, The Netherlands, strain CBS 133792; GenBank
accession number KC163802). Figure 2 shows the phylo-
genetic relationships among Aspergillus section Nigri spe-
cies, including our isolated strain (Table 1). Antifungal
susceptibility testing by microdilution showed that the
strain had MIC values to voriconazole of 1 μg/mL, to posa-
conazole of 0.25 μg/mL, to itraconazole of 0.25 μg/mL,
to fluconazole of > 24 μg/mL, to anidulafungin of 0.125
μg/mL, to amphothericin B of 0.5 μg/mL, and to flucyto-
sine of 2 μg/mL [7].
The patient was treated with liposomal amphothericin
B 5 mg/kg for 6 weeks and imipinem 500 mg/qid for
2 weeks intravenously, followed by prolonged treatment
with voriconazole 300 mg/tid oral for 4 months. With
this treatment the patient recovered from the sinusitis,
but passed away later on that year due to BK virus
encephalitis.
In summary, we describe an immunocompromised pa-
tient suffering from osteomyelitis of the maxillary bone
with a probable invasive A. tubingensis infection of the
surrounding connective tissue after tooth extraction.
This probably resulted in dentogenic pansinusitis pre-
senting as an acute ethmoiditis.
Conclusions
Species belonging to the Aspergillus section Nigri have
been identified as opportunistic pathogens, particularly
in cases of otitis and sinusitis. Of the 25 species in sec-
tion Nigri, A. niger has most often been described as the
cause of infection, however, in most cases species deter-
mination was based only on morphology [8]. Osteomye-




Figure 1 Computed tomography of the head showing A: total
opacification of the ethmoid sinus; B: swollen mucosa of the
maxillary sinus; C: pre-orbital swelling.
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and by A. tubingensis has to the best of our knowledge
not been described. We isolated A. tubingensis from a
purulent wound localized on the surface of the infected
maxillary bone. The immunocompromised patient dete-
riorated while he was treated with antibiotics, and
improved after antimycotics were added. Therefore we
consider this case as a probable invasive aspergillosis.
Alternatively, the infection may have been caused by
yeasts, which were noted in the necrotic tissue sampled
during the debridement 23 days prior to presentation.
We can not rule out involvement of yeasts as well, how-
ever, the cultures of the purulent fluid samples taken
from the bone biopsy wound at presentation were nega-
tive for yeasts.
The subsequent pansinusitis of the patient and acute
ethmoiditis were probably dentogenic, since the purulent
mouth wound after biopsy was ipsilateral to the pre-
orbital swelling. Problematic wound healing of the alveo-
lus after tooth extraction often causes sinusitis due to
fistula of the maxillary sinus and contamination with
dental microbial flora [10]. Alternatively, A. tubingensis
could have invaded the sinus and directly cause the
sinusitis. However, cultures of aspirated secretion from
the sinus cavities were negative, and no fungal strains
were found with histological examination of biopsies
from the mucosa of the sinus cavities.
In recent studies, clinical isolates presumed as A. niger
species have been re-classified by sequencing as A. awa-
mori and A. tubingensis isolates [11-14]. Sequencing of
Aspergillus isolates from transplant patients with invasive
aspergillosis showed that in 9% of cases the causative
agent belonged to Aspergillus section Nigri, and 32% of
these isolates were determined as A. tubingensis [15].
These studies show the potential of A. tubingensis to cause
invasive infections.
Differentiating between A. tubingensis and A. niger
also allows for screening for azole resistance. Thus far,
studies on susceptibility patterns suggest that these may
not be the same for both the species. About 40–50% of
Aspergillus section Nigri strains have a MIC > 1.0 μg/ml
A. piperis CBS 112811T
A. acidus CBS 564.65T
A. costaricaensis CBS 115574T
A. tubingensis CBS 134.48T
CBS 133792
A. vadensis CBS 113365T
A. niger CBS 554.65T
A. brasiliensis CBS 101740T
A. sclerotioniger CBS 115572T
A. carbonarius CBS 111.26T
A. ibericus CBS 121593T
A. sclerotiicarbonarius CBS 121057T
A. ellipticus CBS 707.79T











Figure 2 Maximum Parsimony tree based on β-tubulin sequence data of type strains of Aspergillus section Nigri, including the
Aspergillus tubingensis (CBS 133792) strain isolated from the presented patient. Numbers above branches represent bootstrap values.
Table 1 List of Genbank numbers
Name: GenBank number:
A. acidus CBS 564.65 T FJ629280
A. brasiliensis CBS 101740 T FJ629272
A. carbonarius CBS 111.26 T FJ629276
A. costaricaensis CBS 115574 T FJ629277
A. ellipticus CBS 707.79 T FJ629279
A. heteromorphus CBS 117.55 T FJ629284
A. ibericus CBS 121593 T AM419748
A. niger CBS 554.65 T FJ629288
A. piperis CBS 112811 T FJ629303
A. sclerotiicarbonarius CBS 121057 T EU159229
A. sclerotioniger CBS 115572 T FJ629304
A. tubingensis CBS 134.48 T FJ629305
CBS 133792 KC163802
A. vadensis CBS 113365 T FJ629319
List of GenBank numbers of isolates from Aspergillus section Nigri that were
used for the Maximum Parsimony tree, including the Aspergillus tubingensis
(CBS 133792) strain isolated from the presented patient.
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to voriconazol, and 70–80% to itraconazol. A. tubingen-
sis strains more often have higher MICs to itraconazole
and voriconazole [16,17]. Since there are no clinical
breakpoints for Aspergillus section Nigri available, it is
uncertain how we should interpret these MIC values.
Recently, clinical breakpoints have been presented for
A. fumigatus, proposing MICs ≤ 0.5 μg/ml for voricona-
zole and itraconazole as susceptible [18]. Therefore, in
our hospital we start empirical treatment with liposomal
amphothericin B in case of infection with a black Asper-
gillus, and change to azole therapy based on the results
of species determination by sequencing and antifungal
susceptibility testing.
In conclusion, the presented case shows that A. tubin-
gensis may cause severe invasive infections in immuno-
compromised hosts. Recent developments in species
determination within the Aspergillus section Nigri have
resulted in a trend in recognizing A. tubingensis as an
important opportunistic pathogen. Species determin-
ation of clinical Aspergillus section Nigri isolates by se-
quencing and antifungal susceptibility testing are both
crucial for determining appropriate antifungal therapy,
epidemiological data on susceptibility patterns, and the
pathogenic potential of the various species.
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